ARGX: Rega marang dodolan argenx N.V.
argenx SE (ARGX) leads the development of autoimmune pathology therapies by utilizing unique llama antibodies. Stringent FDA oversight and patent protection establish a robust barrier to entry for competitors. The global launch of drugs is accelerating profit growth and the return on investment for R&D. The revenue multiple trend illustrates the market's revaluation of the business, with the indicator reaching 11.80.
Rincian analitis perusahaan Argenx (ARGX)
- rega saham lan target rega konsensus:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Rasio Utang marang Modal argenx SE|ARGX - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal argenx BVBA|ARGX - Utang perusahaan|Rasio utang marang nilai buku Argenx|ARGX - Kewajiban jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan argenx|Rasio jangkoan perantara argenx.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
ARGX - Bathi resik perusahaan|Prakiraan bathi perusahaan argenx SE|ARGX - Pangali P/E|Rasio prakiraan rega marang bathi argenx N.V.|ARGX - Pangali PEG|Pangali EV/EBITDA Argenx|ARGX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku argenx|ARGX - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham sajroning taun lumaku argenx.com|ARGX - Wutah bathi resik saben saham ing taun iki|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep argenx SE
- data total pendapatan lan volume dodolan:
Analisis fundamental perusahaan:argenx.com (ARGX)
When screening issuer reliability, this indicator compares market capitalization to sales volume to determine how much an investor pays per unit of revenue. The ratio of company value to annual revenue allows for an assessment of the commercialization efficiency of argenx SE drugs, excluding the impact of acquisition costs and focusing on the returns from technological antibody licensing alliances.
Karo sapa argenx SE saingan
biontech.de - Rasio kapitalisasi marang pendapatan|Multiplikator P/S ABVX (Abivax S.A.)|ADMA Biologics Inc (ADMA) - Rega marang dodolan|Protagonist Therapeutics Inc - Multiplikator P/S|IMVT - Multiplikator P/S|Kiniksa Pharmaceuticals (KNSA) - Rasio rega marang pendapatan|grifols.com - Rasio kapitalisasi pasar marang pendapatan|ADPT (Adaptive Biotechnologies Corporation) - Multiplikator P/S|CLDX - Multiplikator rega marang pendapatan|Multiplikator P/S AUPH|BCRX - Rega marang dodolan|Rasio rega marang pendapatan Vera Therapeutics, Inc. VERA|DNTH: Rasio kapitalisasi marang pendapatan|PHVS: Kapitalisasi marang pendapatan|ABCL (AbCellera Biologics Inc.) - Rasio kapitalisasi marang pendapatan|TRML (Tourmaline Corp) - Kapitalisasi marang pendapatan|Precigen Corp - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Pharming Group N.V.|nektar.com (NKTR) - Koefisien rega marang pendapatan|Multiplikator P/S UPB|ZBIO - Rega marang dodolan|Multiplikator P/S IMNM (Immunome Corp)|Multiplikator P/S Gossamer Bio Corp. GOSS|KALV - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan SEPN (septerna.com)|PVLA: Multiplikator P/S|Multiplikator rega marang pendapatan Savara Inc SVRA|Kapitalisasi marang pendapatan RIGL|Rasio kapitalisasi marang pendapatan ANAB (AnaptysBio Inc.)|Rasio rega marang pendapatan Astria Therapeutics (ATXS)|ENGN: Rasio rega marang dodolan|Multiplikator P/S RAPT (RAPT Therapeutics)|Rasio kapitalisasi pasar marang pendapatan JBIO|Aclaris - Multiplikator P/S|KYTX - Multiplikator P/S|Tiziana Life Sciences (TLSA) - Rasio rega marang pendapatan|cabalettabio.com - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Ventyx Biosciences, Inc.|Kapitalisasi marang pendapatan Theratechnologies, Inc. (THTX)|Multiplikator P/S AVTX|Multiplikator P/S Eledon Pharmaceuticals, Inc (ELDN)|Agenus - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan CLYM|Zura Bio - Multiplikator P/S|Koefisien rega marang pendapatan aTyr Pharma Inc ATYR|adagene.com (ADAG) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan Ikena Oncology|Rasio rega marang pendapatan Shattuck Labs Inc|Kapitalisasi marang pendapatan Equillium Bio (EQ)|Kapitalisasi marang pendapatan CNTB (Connect Biopharma)|Multiplikator P/S immunic-therapeutics.com (IMUX)|Rasio rega marang pendapatan Atara Bio ATRA|IFRX: Rasio kapitalisasi marang pendapatan|X4 Pharmaceuticals - Multiplikator P/S|Rega marang dodolan Adicet Bio|CELU: Multiplikator P/S|INmune Bio Inc (INMB) - Multiplikator P/S|Rasio rega marang pendapatan Barinthus Bio|KZR: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S SABS|akaritx.com (AKTX) - Multiplikator rega marang pendapatan|Multiplikator P/S ENLV (Enlivex Therapeutics Ltd.)|Q32 Bio Inc (QTTB) - Rega marang dodolan|GOVX - Rasio rega marang pendapatan|EDSA (Edesa Biotech Corp) - Rasio kapitalisasi marang pendapatan|IBIO (iBio, Inc.) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan CARM|Kapitalisasi marang pendapatan XTLB|BOLT: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan HCW Biologics Inc. (HCWB)|Koefisien rega marang pendapatan aptevotherapeutics.com|Multiplikator P/S AIM (AIM ImmunoTech Inc.)|Aditxt Inc. (ADTX) - Rega marang dodolan|GRI Bio - Multiplikator P/S|XRTX - Multiplikator P/S|ReShape Lifesciences (HIND) - Rasio rega marang pendapatan|Revelation Biosciences Corp - Rasio kapitalisasi pasar marang pendapatan|INDP (Indaptus Therapeutics) - Multiplikator P/S|SCNI - Multiplikator rega marang pendapatan|Kapitalisasi marang pendapatan CALI (CalciMedica, Inc.)|affimed.com - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan Allakos ALLK|HOOK (HOOKIPA Pharma, Inc.) - Rasio rega marang dodolan|IGM Bio - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan ITOS (iteostherapeutics.com)|OCEA: Multiplikator P/S|TC BioPharm (Holdings) Plc (TCBP) - Multiplikator P/S|Rasio rega marang pendapatan Third Harmonic Bio, Inc
